Regenerative Medicine and Stem Cells Technologies

Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial

• Oct 1 2022 - 11:08

CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy

• Sep 21 2022 - 15:07

mRNA has huge potential beyond vaccines. Could it help us cure deadly cancers?

• Sep 21 2022 - 13:31

Positive Stress" Can Make Tooth Stem Cells More Resistant to Disease

• Sep 20 2022 - 15:04

CRISPR-Cas9 Alternatives: Cutting through the Boundaries of Gene Editing

• Sep 20 2022 - 10:40

Expanding The Possibilities with Microorganospheres

• Sep 19 2022 - 14:33

Scientists devise novel methods in their microfluidic technology to produce optimized platforms for tissue and disease modeling

Five lupus patients enter long-lasting remission after immunotherapy

• Sep 19 2022 - 14:17

Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration

• Sep 18 2022 - 15:58

Bluebird wins FDA approval of gene therapy for rare brain disorder

• Sep 18 2022 - 15:42

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

• Sep 14 2022 - 14:25